A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

Ameliorative effect of Hibiscus sabdariffa leaf flavonoid extract on the PSA/CEA/AKT/MMP-9 signaling pathway in benign prostatic hyperplasia-induced rats




TekijätAjiboye, B.O.; Famusiwa, C.D.; Oghenemine, E.E.; Imoleyemi, A.D.; Akinlolu, O.S.; Fatoki, T.H.; Agbolade, A.O.; Ojelabi, A.O.; Ajuwon, O.R.; Oyinloye, B.E.; Iriti, M.; Okesola, M.A.; Ojo, O.A.

KustantajaSpringer Science and Business Media Deutschland GmbH

Julkaisuvuosi2025

Lehti:Comparative Clinical Pathology

Tietokannassa oleva lehden nimiComparative Clinical Pathology

ISSN1618-5641

eISSN1618-565X

DOIhttps://doi.org/10.1007/s00580-025-03703-9

Verkko-osoitehttps://doi.org/10.1007/s00580-025-03703-9

Rinnakkaistallenteen osoitehttps://research.utu.fi/converis/portal/detail/Publication/499722621


Tiivistelmä
Benign prostatic hypertrophy (BPH) is a prevalent condition affecting the prostate gland of elderly men. This study investigated the effects of H. sabdariffa leaf flavonoid extracts on BPH induction in rats. Thirty-six male Wistar rats were split into six groups: normal controls, BPH-induced rats (3 mg/kg testosterone), and rats treated with BPH-induced with flavonoid extract (300 mg/kg and 150 mg/kg) or a standard drug (1 mg/kg finasteride). After 28 days, biochemical, histological, and molecular parameters were assessed. The extract rich in flavonoids from H. sabdariffa markedly (p < 0.05) decreased the amount of MDA and enhanced the activities of antioxidant enzymes in rats administered with BPH. The extracts substantially attenuated inflammatory markers such as IL-6, IL-1β, and TNFα levels. Histological examination revealed improved prostate architecture in the treated groups in contrast to those in BPH-induced rats. Additionally, substantial (p < 0.05) downregulation of CEA, AKT, MMP9, and PSA in the extract-treated groups was observed. HPLC characterization identified prominent flavonoids, with quercetin being the most abundant bioactive compound. The outcome of this study proffers the therapeutic activities of H. sabdariffa flavonoid extract on BPH rat model.

Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.




Julkaisussa olevat rahoitustiedot
Dr. Oluwafemi Ojo has been co-funded by the European Union’s Horizon Europe Framework Programme for Research and Innovation 2021-2027 under the Marie Sklodowska-Curie action grant agreement No. 101126611.
Open Access funding provided by University of Turku (including Turku University Central Hospital).


Last updated on 2025-29-09 at 15:35